Montelukast Sodium Granule
Product Images NDC 27241-015

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 27241-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Montelukast 10mg 30

The label for Montelukast Sodium 10 mg chewable tablets by Ajanta Pharma USA Inc. indicates 30 tablets per package. It includes storage instructions to keep the tablets between 20°C to 25°C with permitted excursions, caution to keep out of reach of children, and a note that the package is child-resistant. The label specifies the drug is for adults 15 years and older and mentions the tablet contains 10.4 mg Montelukast Sodium USP equivalent to 10 mg Montelukast.*

FDA Label Image

Montelukast 10mg 90

Label for Montelukast Sodium 10 mg chewable tablets, USP, containing 90 tablets per package. The label indicates the product is marketed by Ajanta Pharma USA Inc., with storage instructions to keep the package at 20-25°C and protect from moisture and light. The label includes the NDC 27241-018-09 and states the tablets are for adults 15 years and older.*

FDA Label Image

Montelukast 4mg 30

Montelukast Sodium 4 mg chewable tablets label for pediatric patients 2-5 years of age. The label indicates the product is child-resistant, dispensed in a 30-tablet package, marketed by Ajanta Pharma USA Inc., and manufactured in India. Instructions include storage conditions, and the label contains a barcode and the NDC 27241-016.*

FDA Label Image

Montelukast 4mg 90

Montelukast Sodium 4 mg chewable tablets label by Ajanta Pharma USA Inc. The label indicates a package of 90 tablets intended for pediatric patients aged 2-5 years. It includes storage instructions, manufacturer details, NDC 27241-016-09, and notes the product is child-resistant and contains phenylalanine. The label has space for lot and expiration dates and includes a UPC barcode.*

FDA Label Image

Montelukast 5mg 30

Label for Montelukast Sodium chewable tablets USP 5 mg, distributed by Ajanta Pharma USA Inc. The label includes storage instructions to keep at controlled room temperature and out of reach of children. It specifies the package contains 30 tablets and carries a barcode, NDC 27241-017-03. The label cautions phenylketonurics about phenylalanine content in each tablet.*

FDA Label Image

Montelukast 5mg 90

Montelukast Sodium 5 mg chewable tablets label by Ajanta Pharma USA Inc. The label states it contains 90 tablets, is for pediatric patients 6-14 years old, and emphasizes child-resistant packaging. Storage instructions specify 20-25°C with excursions to 15-30°C. The label warns of phenylketonurics content and includes regulatory details and a barcode.*

FDA Label Image

Figure_01 (Montelukast Fig1)

Line graph showing change in height in centimeters over weeks of treatment for three groups: Montelukast sodium chewable tablets 5 mg, beclomethasone 336 mcg, and placebo. The x-axis represents weeks on treatment from -19 to 56 weeks; the y-axis shows height change from -3 to 7 cm. The graph demonstrates height changes compared among the treatment groups over time, with noted very small standard errors.*

FDA Label Image

Figure_2 (Montelukast Fig2)

A line graph depicting mean percent change from baseline over weeks in treatment and a washout period. It compares results for Montelukast sodium tablet and placebo groups, with time on the x-axis (weeks) and mean percent change on the y-axis.*

FDA Label Image

Montelukast Granules 4mg

Packaging label for Montelukast Sodium Oral Granules USP 4 mg in sachet form. The label indicates it is for pediatric patients aged 6 months to 5 years. The package contains 30 sachets. The product is marketed by Ajanta Pharma USA Inc. and includes storage instructions and usage directions. The label displays the NDC 27241-015-31.*

FDA Label Image

Structure (Montelukast Str)

Chemical structure of Montelukast Sodium, showing its molecular arrangement including aromatic rings and functional groups, consistent with the active ingredient in MONTELUKAST SODIUM tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.